Targeted therapy for metastatic breast cancer
- PMID: 17192546
- DOI: 10.1056/NEJMe068260
Targeted therapy for metastatic breast cancer
Comment on
-
Lapatinib plus capecitabine for HER2-positive advanced breast cancer.N Engl J Med. 2006 Dec 28;355(26):2733-43. doi: 10.1056/NEJMoa064320. N Engl J Med. 2006. PMID: 17192538 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical